Oralin cleared for phase III trials in Ecuador; regulatory clearance expected by year-end Oct. 13, 1998
Scientists report significant finding related to the genetics of insulin-dependent diabetes Oct. 13, 1998
Vitronectin receptor antagonists from HMR particularly useful as bone resorption inhibitors Oct. 9, 1998
ZK-137316: chronic, low-dose regimen prevents pregnancy in monkeys with little cycle disruption Oct. 8, 1998
RSS